AdrenoMed advances personalized septic shock therapy as new sepsis guidelines and U.S. policy highlight urgent unmet need
2026 Surviving Sepsis Campaign Guidelines and U.S. SEPSIS Act reinforce the need to close persistent therapeutic gaps in septic shock and improve survival through personalized, evidence-based approaches
























